Status:
UNKNOWN
Multicenter Comparison of Interictal HFO as a Predictor of Seizure Freedom
Lead Sponsor:
University of Zurich
Collaborating Sponsors:
McGill University
University of Michigan
Conditions:
Epilepsy Intractable
Eligibility:
All Genders
Brief Summary
In drug-resistant focal epilepsy, interictal high frequency oscillations (HFO) recorded from intracranial EEG (iEEG) may provide clinical information for delineating epileptogenic brain tissue. The iE...
Detailed Description
We use an automated data-independent prospective definition of clinically relevant HFO that has been validated in data from two independent epilepsy centers. In this study, we combine retrospectively ...
Eligibility Criteria
Inclusion
- Data as provided from the participating center
Exclusion
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05332990
Start Date
May 1 2022
End Date
May 1 2024
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich, Neurosurgery
Zurich, Canton of Zurich, Switzerland, 8091